Kits Eyecare (TSX:KITS) Reports Preliminary Q4 and Full Year 2025 Results

VANCOUVER, BC — January 7, 2026 — Leads & Copy — Kits Eyecare Ltd. (TSX: KITS) has released selected preliminary unaudited results for its fourth quarter and full year ended December 31, 2025.

Total revenue for the fourth quarter increased 20% year-over-year to approximately $53.9 million. Glasses revenue expanded approximately 33% year-over-year to $8.7 million, with units increasing 43% year-over-year to 119,000 units. The adjusted EBITDA margin is approximately 4.0 to 5.0% of revenue.

Full year revenue increased 27% year-over-year to approximately $202.5 million. The adjusted EBITDA margin expanded year-over-year to approximately 5.0 to 6.0% of revenue. New customer additions increased 30% year-over-year to approximately 393,000.

The company anticipates reporting the audited fourth quarter and full year 2025 results in early March 2026, with details for the fourth quarter 2025 conference call to be disclosed in February.

KITS (TSX: KITS) offers prescription glasses and contact lenses through its vertically integrated digital platform. The company utilizes in-house lens manufacturing and OpticianAI-powered digital fit technology.

Source: KITS Eyecare Ltd.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.